Browsing by Author "Tuzun, B."
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Scopus Exploring Benzo[b][1,4]Thiazine Derivatives: Multitarget Inhibition, Structure–Activity Relationship, Molecular Docking, and ADMET Analysis(John Wiley and Sons Inc, 2024) Alishba; Ali, I.; Hameed, S.; Khan, K.M.; Salar, U.; Taha, M.; Sadeghian, N.; Taslimi, P.; Tuzun, B.; Özerkan, D.; Dedeakayogullari, H.; Ulukaya, E.A series of benzothiazine derivatives (1–17) were synthesized via an intermolecular cyclocondensation reaction involving 2-aminothiophenol (i) and substituted phenacyl bromide (ii). Structural elucidation of these synthetic derivatives utilized EI–MS, HR-EIMS, 1H NMR, and 13C NMR spectroscopic techniques. The synthesized analogs were evaluated against key enzyme targets (acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and α-glucosidase (α-Glu)) and tested for cytotoxicity against various cancer cell lines. Six compounds were selected based on their inhibition profiles, exhibiting significant inhibitory potential against enzymes. In silico studies corroborated the observed inhibitory activities, aligning closely with experimental outcomes. Additionally, an ADME/T study provided insights into pharmacokinetic and safety profiles, identifying promising candidates for future drug development efforts.Web of Science Exploring Benzo[b][1,4]Thiazine Derivatives: Multitarget Inhibition, Structure-Activity Relationship, Molecular Docking, and ADMET Analysis(2024.01.01) Alishba, I.; Ali, I.; Hameed, S.; Khan, K.M.; Salar, U.; Taha, M.; Sadeghian, N.; Taslimi, P.; Tuzun, B.; Özerkan, D.; Dedeakayogullari, H.; Ulukaya, E.A series of benzothiazine derivatives (1-17) were synthesized via an intermolecular cyclo condensation reaction involving 2-aminothiophenol (i) and substituted phenacyl bromide (ii). Structural elucidation of these synthetic derivatives utilized EI-MS, HR-EIMS, H-1 NMR, and C-13 NMR spectroscopic techniques. The synthesized analogs were evaluated against key enzyme targets (acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and alpha-glucosidase (alpha-Glu)) and tested for cytotoxicity against various cancer cell lines. Six compounds were selected based on their inhibition profiles, exhibiting significant inhibitory potential against enzymes. In silico studies corroborated the observed inhibitory activities, aligning closely with experimental outcomes. Additionally, an ADME/T study provided insights into pharmacokinetic and safety profiles, identifying promising candidates for future drug development efforts.